Estados Unidos · Plataformas y datos · The Motley Fool

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Publicado por The Motley Fool · Estados Unidos hace 1 h

Resumen detallado

PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Resumen detallado

También te puede interesar

How much in Roth conversions can you do in 2027 with the new tax brackets?

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Best Stocks Under $5

Fed rate call leaves stock investors watching December closely

Banca Sistema Completes Banca CF+ Merger and Capital Increase

The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?

Resumen detallado

Compartir

También te puede interesar

How much in Roth conversions can you do in 2027 with the new tax brackets?

Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

Heavy rain floods tents housing Gaza displaced people, aid shortages hamper response

Best Stocks Under $5

Fed rate call leaves stock investors watching December closely

Banca Sistema Completes Banca CF+ Merger and Capital Increase